Is the source legitimate? The article isn't an actual paper it reads like a scammy ad for the product. With red flag words like referring to nitrous oxide as a "nano molecule". Technically correct but in context we wouldn't call a simple small molecule a form of nanotechnology, when the word is used we mean complex atomic scale structures.
I mean if it were legit, I am thinking how the flu and common cold would be vulnerable to the same mechanism.
I read the clinical trial registration and it seems like there's a lot of Goodharting going on when you pass this off as a cure for COVID-19.
From the preregistration it's interesting what endpoints they have. The primary endpoint is "Measure the efficacy of NONI compared to saline placebo control to shorten the duration of COVID-19 viral infectivity".
That sounds to me like the idea is if you put the stuff in your nasal pathways then you kill the virus in the nasal pathways and as a result it's less likely that you infect other people.
In the list they have as outcomes:
3. To Measure the efficacy of NONI in prevention of progression of COVID-19 [ Time Frame: 28 days ]
Measure the proportion of subjects requiring hospitalization or ER/ED visits for COVID-19/flu-like symptoms
4. To measure reduction of patient reported outcome (PRO) of clinical cold score symptoms and quality of life (QoL) in subjects with COVID-19 [ Time Frame: 6 days ]
5. To measure reduction of patient reported outcome (PRO) of clinical cold score symptoms and quality of life in subjects with COVID-19
The press release doesn't seem to indicate that they found a statistical significant result on either of those outcomes and I would expect that they would have put it into the press release if they found it.
This suggests the treatment might make you less infectious to other people but at the same time it doesn't provide clinical benefits to the person being treated.
It might be clinically useful to be able to reduce the infectiousness of patients but that's far from a cure for COVID-19.
Not implausible, similar RCTs exist for other nasal sprays ( But it would be important to know how many hours after application of the spray viral load was measured). This is for iota-carrageenan from a month ago, and widely available in some European countries.
"In the multicenter, randomized, double-blind, controlled CARR-COV-02 study, 394 healthcare staff were randomly assigned to receive iota-carrageenan nasal spray (N = 199) or placebo (N = 195) four times per day. [...]The percentage of participants that developed COVID-19 was significantly lower in the group that received the iota-carrageenan spray compared to placebo (1.0% vs 5.1%, respectively; relative risk reduction for disease of 80.4 %; 95 % CI = 25-95 % )."
But it would be somewhat surprising if it were to protect you from complications once you are actually infected, as viral load in the throat or lungs would not be reduced.
https://www.marinomed.com/en/news/marinomed-biotech-ag-announces-clinical-trial-at-swansea-university-medical-school-to-investigate-efficacy-of-carragelose-in-preventing-covid-19-infections
According to https://www.biospace.com/article/releases/uk-clinical-trial-confirms-sanotize-s-breakthrough-treatment-for-covid-19/
Update: the link to the company's site: https://sanotize.com/covid-19/
This sounds too good to be true, but says it's been RCT'd. What are the odds that by using a nasal spray for 3 days once you get positive test results, or even once you have symptoms would protect you from complications?